Exo Therapeutics
PrivateLast Round
Series B
Oct 5, 2021
Total Funding Raised
$103M
Company Overview
Exo Therapeutics is a biotechnology company that develops small-molecule drug candidates targeting exosites to reprogram enzyme activity for the treatment of oncology and inflammatory diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Exo Therapeutics Comparables
Compare Exo Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| HotSpot Therapeutics | 85% | |
| Nutshell Therapeutics | 79% | |
| Eisbach Bio GmbH | 76% | |
Exo Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Oct 5, 2021 | ||||
| Series A | Dec 16, 2020 |
Exo Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Newpath Partners | Series B, Series A |
| Morningside Ventures | Series B |
| BVF Partners L.P. | Series B |
| CRV | Series B, Series A |
| Casdin Capital | Series B |
| Nextech Invest | Series B |
| 6 Dimensions Capital | Series B, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Dec 16, 2020
$25M round led by CRV.
Exo Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Exo Therapeutics's valuation, stock price, and market status.